Strategic hires in February follows the best January on record for biopharma deals
We hope you are enjoying Optimum’s weekly newsletter – subscribe on LinkedIn today so you never miss an edition.
Our clients Loqus23 Therapeutics and Ona Therapeutics continued the stream of good news for February with key leadership appointments.
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
LoQus23 Therapeutics Ltd, a private biotechnology company investigating small molecule drugs that could stop the pathogenic triplet expansion that is the cause and driver of Huntington’s Disease, myotonic dystrophy type 1, and other triplet repeat expansion diseases, on Tuesday announced the appointment of Dr Cyrus Mozayeni as its Chair of the Board of Directors.
Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types
Ona Therapeutics, a global biotech company pioneering first-in-class antibody-drug conjugates (ADCs), on Wednesday, announced key leadership appointments to support rapid growth and pipeline advancement of its first-in-class ADCs targeting multiple large solid tumour types.
Dr. Aleix Prat, a global leader in drug and biomarker development, has been appointed Chair of the Advisory Board, alongside Dr. Jutta Amersdorffer as its Chief Medical Officer and Stéphane Durant des Aulnois as its Chief Financial Officer.
Optimum TV
It was a busy week for Stephen Adams and Optimum TV, with two fantastic episodes featuring clients AMSilk and Akribion Therapeutics.
Fibres for the clothes of tomorrow won’t be grown in fields, sheared from animals or spun from oil-based polymers – but assembled from proteins brewed up in bio-fermenters, Ulrich Scherbel of AMSilk tells Optimum TV.
Watch this fascinating episode on how microbes will be used to make textiles, and a host of other everyday materials below.
In the second episode of the week, discover how Akribion Therapeutics has learnt how to “shred” specific strands of RNA and DNA – thus killing cells in a highly targeted fashion – in our latest episode of Optimum TV with Akribion’s Co-CEOs, Lukas Linnig, CFA and Dr Michael Krohn.
Optimum’s Hot Topic
Check out this week’s hot topic – the best January on record for biopharma deals! Read Richard Staines’ analysis here.
Upcoming Industry Events
Six weeks until the 21st Annual Anglonordic Life Science Conference. Optimum has programmed the agenda and what a stellar line up of #lifescience leaders it is! If you’ve not yet registered, what are you waiting for?
Reach out to use Optimum’s discount code – Contact@optimumcomms.com
That’s all folks! To stay in the know – subscribe to Optimum’s weekly wrap-up today.
